• $6,553.00
    Market Cap
  • -99.97%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2023
06/30/2022
06/30/2021
Income Statement
Total Operating Revenue
111,579
+41,689.89%
267
-100.00%
6.5M
N/A
Cost of Revenue
111,359
+6,270.65%
1,748
-99.94%
2.9M
N/A
Gross Profit
220
+114.85%
-1,481
-100.04%
3.6M
N/A
Sales and Marketing Expense
1.3M
+37.48%
934,927
-19.98%
1.2M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
686,676
-17.32%
830,545
-5.49%
878,794
N/A
Total Operating Expenses
1.8M
+11.93%
1.6M
-7.40%
1.8M
N/A
Operating Profit
-1.8M
+11.81%
-1.6M
-188.41%
1.9M
N/A
Interest Income
113,615
-28.03%
157,860
+14.82%
137,485
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
113,615
-28.03%
157,860
+14.82%
137,485
N/A
Total Nonoperating Income and Expense
1.4M
+10.56%
1.3M
+722.52%
157,675
N/A
Income before Taxes
-408,772
+16.45%
-351,016
-117.36%
2.0M
N/A
Income Taxes
N/A
N/A
2,934
-99.60%
730,461
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-408,772
+15.49%
-353,950
-127.41%
1.3M
N/A
Net Income from Continuing Operations Applicable to Common
-408,772
+16.45%
-351,016
-117.36%
2.0M
N/A
Basic EPS and Net Income
-0.006
+14.81%
-0.005
-127.41%
0.02
N/A
Diluted EPS and Net Income
-0.006
+14.81%
-0.005
-127.41%
0.02
N/A
Basic Weighted Average Shares
65.5M
0.00%
65.5M
0.00%
65.5M
N/A
Diluted Weighted Average Shares
65.5M
0.00%
65.5M
0.00%
65.5M
N/A
Balance Sheet
Cash and Cash Equivalents
47,246
-99.89%
44.8M
+1.00%
44.3M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
47,246
-99.89%
44.8M
+1.00%
44.3M
N/A
Total Current Assets
41.0M
-10.15%
45.6M
-4.47%
47.7M
N/A
Accumulated Depreciation
3.8M
-2.79%
3.9M
+5.68%
3.7M
N/A
Property and Plant and Equipment and Net
2.7M
-13.64%
3.2M
-13.00%
3.6M
N/A
Total Long-Term Assets
2.7M
-13.64%
3.2M
-13.00%
3.6M
N/A
Total Assets
45.1M
-11.16%
50.7M
-5.83%
53.9M
N/A
Income Taxes Payable
137,585
+3.44%
133,005
-24.58%
176,359
N/A
Total Short-Term Debt
N/A
N/A
6.8M
-16.34%
8.1M
N/A
Total Current Liabilities
6.0M
-24.82%
7.9M
-12.82%
9.1M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
6.0M
-24.82%
7.9M
-12.82%
9.1M
N/A
Retained Earnings
41.3M
-0.98%
41.7M
-0.84%
42.1M
N/A
Total Stockholders Equity
39.1M
-8.63%
42.8M
-4.40%
44.8M
N/A
Total Shares Outstanding
65.5M
0.00%
65.5M
0.00%
65.5M
N/A
Cash Flow
Cash from Operating Activities
-42.3M
-2,098.01%
2.1M
-61.92%
5.6M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
8,582
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
-13,655
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Financials Ratio
Gross Margin
0.20%
+100.04%
-554.68%
-1,088.85%
56.09%
N/A
Operating Margin
-1,651.39%
-99.73%
-617,199.63%
-2,150,044.53%
28.71%
N/A
Return on Assets
-0.85%
+26.10%
-0.68%
-126.75%
2.53%
N/A
Return on Equity
-1.00%
+23.48%
-0.81%
-126.43%
3.06%
N/A
Revenue Growth
41,689.89%
+41,791.60%
-100.00%
+188.78%
-34.63%
N/A
Current Ratio
6.86
+19.52%
5.74
+9.58%
5.24
N/A
Cash Ratio
0.008
-99.86%
5.64
+15.86%
4.87
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow